These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1044 related items for PubMed ID: 19630367

  • 1. [Controlled release melatonin (Circadin) in the treatment of insomnia in older patients: efficacy and safety in patients with history of use and non-use of hypnotic drugs].
    Zisapel N.
    Harefuah; 2009 May; 148(5):337-41, 348. PubMed ID: 19630367
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, Zisapel N.
    Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
    [Abstract] [Full Text] [Related]

  • 3. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
    Lemoine P, Nir T, Laudon M, Zisapel N.
    J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082
    [Abstract] [Full Text] [Related]

  • 4. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin®) in insomnia].
    Quera-Salva MA, Claustrat B.
    Encephale; 2018 Dec; 44(6):548-557. PubMed ID: 30107892
    [Abstract] [Full Text] [Related]

  • 5. Sleep complaints: Whenever possible, avoid the use of sleeping pills.
    Prescrire Int; 2008 Oct; 17(97):206-12. PubMed ID: 19536941
    [Abstract] [Full Text] [Related]

  • 6. [Melatonin--a natural hypnotic?].
    Saletu B.
    Wien Klin Wochenschr; 1997 Oct 03; 109(18):714-21. PubMed ID: 9441514
    [Abstract] [Full Text] [Related]

  • 7. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.
    Luthringer R, Muzet M, Zisapel N, Staner L.
    Int Clin Psychopharmacol; 2009 Sep 03; 24(5):239-49. PubMed ID: 19584739
    [Abstract] [Full Text] [Related]

  • 8. Melatonin for primary insomnia?
    Drug Ther Bull; 2009 Jul 03; 47(7):74-7. PubMed ID: 19567841
    [Abstract] [Full Text] [Related]

  • 9. Ramelteon for the treatment of insomnia.
    Borja NL, Daniel KL.
    Clin Ther; 2006 Oct 03; 28(10):1540-55. PubMed ID: 17157111
    [Abstract] [Full Text] [Related]

  • 10. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.
    Sleep Med; 2006 Jun 03; 7(4):312-8. PubMed ID: 16709464
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug 03; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 12. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
    Wade AG, Crawford G, Ford I, McConnachie A, Nir T, Laudon M, Zisapel N.
    Curr Med Res Opin; 2011 Jan 03; 27(1):87-98. PubMed ID: 21091391
    [Abstract] [Full Text] [Related]

  • 13. Ramelteon: a novel approach in the treatment of insomnia.
    Reynoldson JN, Elliott E, Nelson LA.
    Ann Pharmacother; 2008 Sep 03; 42(9):1262-71. PubMed ID: 18648020
    [Abstract] [Full Text] [Related]

  • 14. Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia.
    Lemoine P, Zisapel N.
    Expert Opin Pharmacother; 2012 Apr 03; 13(6):895-905. PubMed ID: 22429105
    [Abstract] [Full Text] [Related]

  • 15. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
    Otmani S, Demazières A, Staner C, Jacob N, Nir T, Zisapel N, Staner L.
    Hum Psychopharmacol; 2008 Dec 03; 23(8):693-705. PubMed ID: 18763235
    [Abstract] [Full Text] [Related]

  • 16. Treatment options for insomnia--pharmacodynamics of zolpidem extended-release to benefit next-day performance.
    Bogan RK.
    Postgrad Med; 2008 Sep 03; 120(3):161-71. PubMed ID: 18824834
    [Abstract] [Full Text] [Related]

  • 17. Sleeping through the night: are extended-release formulations the answer?
    Calamaro C.
    J Am Acad Nurse Pract; 2008 Feb 03; 20(2):69-75. PubMed ID: 18271761
    [Abstract] [Full Text] [Related]

  • 18. Indiplon: a nonbenzodiazepine sedative-hypnotic for the treatment of insomnia.
    Marrs JC.
    Ann Pharmacother; 2008 Jul 03; 42(7):1070-9. PubMed ID: 18594049
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
    Lydiard RB, Lankford DA, Seiden DJ, Landin R, Farber R, Walsh JK.
    J Clin Sleep Med; 2006 Jul 15; 2(3):309-15. PubMed ID: 17561543
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
    Walsh JK, Soubrane C, Roth T.
    Am J Geriatr Psychiatry; 2008 Jan 15; 16(1):44-57. PubMed ID: 18165461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.